Details for New Drug Application (NDA): 216137
✉ Email this page to a colleague
NDA 216137 describes VALBENAZINE TOSYLATE, which is a drug marketed by Lupin Ltd and Zydus Lifesciences and is included in two NDAs. Additional details are available on the VALBENAZINE TOSYLATE profile page.
The generic ingredient in VALBENAZINE TOSYLATE is valbenazine tosylate. One supplier is listed for this compound. Additional details are available on the valbenazine tosylate profile page.
The generic ingredient in VALBENAZINE TOSYLATE is valbenazine tosylate. One supplier is listed for this compound. Additional details are available on the valbenazine tosylate profile page.
Summary for 216137
| Tradename: | VALBENAZINE TOSYLATE |
| Applicant: | Zydus Lifesciences |
| Ingredient: | valbenazine tosylate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 40MG BASE | ||||
| Approval Date: | Aug 7, 2024 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 60MG BASE | ||||
| Approval Date: | Aug 7, 2024 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 80MG BASE | ||||
| Approval Date: | Aug 7, 2024 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
